Literature DB >> 26490035

Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.

Jose M Trigo1, Bernard Le Foll2,3,4,5,6,7,8.   

Abstract

RATIONALE: Tobacco smoking is still a major population health issue. The endocannabinoid system has been shown to control drug-seeking behaviors. There are two main endocannabinoids: anandamide degraded by fatty acid amide hydrolase (FAAH) and 2-arachidonoylglycerol (2-AG) degraded by monoacylglycerol lipase (MAGL).
OBJECTIVES: The role of MAGL has only been explored recently, and so far, no study have been performed to evaluate the effects of MAGL inhibitor on nicotine reinforcing properties and cue-induced reinstatement of nicotine seeking.
METHODS: Here, we investigated the effects of the MAGL inhibitor JZL184 on nicotine self-administration under fixed and progressive-ratio schedules of reinforcement and on cue-induced reinstatement of nicotine seeking in mice. We also evaluated the effects of JZL184 on food self-administration for possible non-specific effects.
RESULTS: JZL184 (0, 8, and 16 mg/kg) did not affect food taking, nicotine taking, or motivation for nicotine. MAGL inhibition by JZL184 (16 mg/kg) increased reinstatement of previously extinguished nicotine seeking induced by presentation of nicotine-associated cues, but did not produce reinstatement on its own.
CONCLUSIONS: This study implicates involvement of 2-AG in nicotine-seeking behaviors.

Entities:  

Keywords:  2-arachidonoylglycerol; Mice; Nicotine; Reinstatement; Self-administration

Mesh:

Substances:

Year:  2015        PMID: 26490035     DOI: 10.1007/s00213-015-4117-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

Review 1.  Involvement of the endocannabinoid system in drug addiction.

Authors:  Rafael Maldonado; Olga Valverde; Fernando Berrendero
Journal:  Trends Neurosci       Date:  2006-02-17       Impact factor: 13.837

2.  Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.

Authors:  P P Muldoon; J Chen; J L Harenza; R A Abdullah; L J Sim-Selley; B F Cravatt; M F Miles; X Chen; A H Lichtman; M I Damaj
Journal:  Br J Pharmacol       Date:  2015-02       Impact factor: 8.739

3.  The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeys.

Authors:  Zuzana Justinová; Sevil Yasar; Godfrey H Redhi; Steven R Goldberg
Journal:  J Neurosci       Date:  2011-05-11       Impact factor: 6.167

4.  Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training.

Authors:  Beata Bystrowska; Irena Smaga; Małgorzata Frankowska; Małgorzata Filip
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-12-12       Impact factor: 5.067

5.  Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training.

Authors:  Christie D Fowler; Paul J Kenny
Journal:  Neuropharmacology       Date:  2011-05-25       Impact factor: 5.250

6.  Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.

Authors:  Steven G Kinsey; Scott T O'Neal; Jonathan Z Long; Benjamin F Cravatt; Aron H Lichtman
Journal:  Pharmacol Biochem Behav       Date:  2010-12-08       Impact factor: 3.533

7.  Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.

Authors:  J R Savinainen; T Järvinen; K Laine; J T Laitinen
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).

Authors:  Caroline Cohen; Ghislaine Perrault; Guy Griebel; Philippe Soubrié
Journal:  Neuropsychopharmacology       Date:  2005-01       Impact factor: 7.853

9.  Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.

Authors:  Maria Scherma; Leigh V Panlilio; Paola Fadda; Liana Fattore; Islam Gamaleddin; Bernard Le Foll; Zuzana Justinová; Eva Mikics; Jozsef Haller; Julie Medalie; Jessica Stroik; Chanel Barnes; Sevil Yasar; Gianluigi Tanda; Daniele Piomelli; Walter Fratta; Steven R Goldberg
Journal:  J Pharmacol Exp Ther       Date:  2008-08-25       Impact factor: 4.030

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  5 in total

Review 1.  Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.

Authors:  Ewa Galaj; Zheng-Xiong Xi
Journal:  CNS Drugs       Date:  2019-10       Impact factor: 5.749

Review 2.  The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.

Authors:  Yann Chye; Erynn Christensen; Nadia Solowij; Murat Yücel
Journal:  Front Psychiatry       Date:  2019-02-19       Impact factor: 4.157

3.  Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.

Authors:  Lakshmi Ramachandran Nair; Xiu Liu
Journal:  J Addict Res Ther       Date:  2019-04-15

4.  Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats.

Authors:  Yoko Nawata; Taku Yamaguchi; Ryo Fukumori; Tsuneyuki Yamamoto
Journal:  Int J Neuropsychopharmacol       Date:  2019-02-01       Impact factor: 5.176

Review 5.  New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence.

Authors:  Rocio Saravia; Marc Ten-Blanco; Inmaculada Pereda-Pérez; Fernando Berrendero
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.